Linagliptin Side Effects
Some side effects of linagliptin may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to linagliptin: oral tablet
Get emergency medical help if you have any of these signs of an allergic reaction while taking linagliptin: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking linagliptin and call your doctor at once if you have a serious side effect such as:
-
pancreatitis - severe pain in your upper stomach spreading to your back, nausea and vomiting, loss of appetite, fast heart rate; or
-
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash.
Less serious side effects of linagliptin may include:
-
runny or stuffy nose, sore throat;
-
cough;
-
weight gain;
-
muscle or joint pain;
-
headache; or
-
back pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to linagliptin: oral tablet
Metabolic
Metabolic side effects have included hypoglycemia, hyperlipidemia, hypertriglyceridemia and weight gain.
Hypersensitivity
Hypersensitivity side effects have included urticaria, angioedema, localized skin exfoliation, and bronchial hyperreactivity.
Respiratory
Respiratory side effects have included nasopharyngitis and cough. Side effects reported when linagliptin was used in combination with glimepiride and metformin include upper respiratory infection.
Musculoskeletal
Musculoskeletal side effects have included arthralgia, back pain and myalgia. Side effects reported when linagliptin was used in combination with glimepiride and metformin include pain in extremities.
Endocrine
Endocrine side effects have included pancreatitis.
Nervous system
Nervous system side effects have included headache.
Gastrointestinal
Gastrointestinal side effects reported include diarrhea. Side effects reported when linagliptin was added on to basal insulin therapy include constipation.
Genitourinary
Genitourinary side effects reported when linagliptin was used in combination with specific anti-diabetic agents include urinary tract infection.
Other
Increases in uric acid were reported more frequently in patients treated with linagliptin than placebo.
More linagliptin resources
- linagliptin MedFacts Consumer Leaflet (Wolters Kluwer)
- linagliptin Advanced Consumer (Micromedex) - Includes Dosage Information
- Linagliptin Professional Patient Advice (Wolters Kluwer)
- Linagliptin Monograph (AHFS DI)
- Tradjenta Prescribing Information (FDA)
- Tradjenta Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


